The EU’s revised MDR 2017/745 was introduced in 2017 and became fully applicable to all medical devices on 27 May 2024.

Rice University and Baylor College of Medicine have received $2.8 million in funding from the National Heart, Lung, and Blood ...

干细胞治疗的最新进展表明，静脉输注干细胞具有治疗危及生命的肺纤维化的潜力。然而，它也面临着局限性，如缺乏对细胞功能的控制和植入后宿主的快速清除。这项研究中开发了一种创新的PF治疗方法，通过气管给药的微流体模板化的干细胞微胶囊，有效地逆转了炎症和纤维化损伤的进展。研究结果显示了水凝胶微胶囊化可以增强供体间充质干细胞（MSCs）在宿主体内的持久性，同时驱动MSCs显著增强其治疗功能，包括免疫调节和基质 ...

In addition, these Regulatory T cells regulate other injury healing cells to the site, flooding the injury with beneficial ...

The worldwide incidence of food allergies continues to increase especially in children therefore, prevention remain a public ...

Tiziana Life Sciences announces $4 million grant awarded by NIH to study anti-CD3 in Alzheimer’s disease: New York Saturday, September 21, 2024, 14:00 Hrs [IST] Tiziana Life Sci ...

but additionally shapes the infant's gut microbiota and instructs immunomodulation. Reflecting maternal environmental exposition and in virtue of its multiple mechanism of action, secretory IgA in ...

Alzheimer’s disease is the most common form of dementia, affecting more than 6 million people in the United States alone. Despite extensive research, effective treatments remain limited, and the need ...

Monash University researchers have discovered a blood cell that, when introduced to a bone, muscle, or skin injury, has the ...

Analyst Cory Jubinville, PhD of LifeSci Capital maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), retaining the ...